PHI with Aortic aneurysm
How does this condition affect your private health insurance?
An Aortenaneurysma, or aortic aneurysm, is a localized, pathological dilation or bulge in the wall of the aorta, the body's largest artery. This weakening and expansion can occur anywhere along its length, most commonly in the abdominal section (abdominal aortic aneurysm, AAA) or the thoracic section (thoracic aortic aneurysm, TAA). Often asymptomatic, these "silent killers" can grow gradually over years. Their greatest danger lies in the potential for rupture, which leads to massive, life-threatening internal hemorrhage and shock. Contributing factors include atherosclerosis, hypertension, genetic connective tissue disorders, and older age. Early detection through imaging and timely intervention are critical to prevent fatal complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Years of silent growth before detection, with acute onset of symptoms if rupture or dissection occurs.
Duration of Illness (Lifetime)
Chronic condition requiring lifelong monitoring or management if detected, potentially resolved with successful surgical intervention but risk factors remain.
Cost of Treatment (Initial)
High, ranging from tens to hundreds of thousands of dollars for surgical or endovascular repair.
Cost of Treatment (Lifetime)
Substantial, encompassing initial repair, lifelong follow-up imaging, potential re-interventions, and management of associated conditions.
Mortality Rate
Low (1-5%) for elective repair, but extremely high (50-80% or more) if rupture occurs.
Risk of Secondary Damages
High in case of rupture (massive hemorrhage, shock, multi-organ failure). Untreated, it can lead to dissection, embolism, or organ ischemia.
Probability of Full Recovery
Low if rupture occurs. If repaired electively, patients can recover well but typically require lifelong surveillance; complete recovery without any long-term management is unlikely.
Underlying Disease Risk
High: frequently associated with atherosclerosis, hypertension, hyperlipidemia, smoking, Marfan syndrome, Ehlers-Danlos syndrome, and other connective tissue disorders.